Functional promoter -1271G>C variant of HSPB1 predicts lung cancer risk and survival.

PURPOSE Heat-shock protein 27 (Hsp27), encoded by HSPB1, plays crucial roles in tumorigenesis and cell survival and is reported to be an independent prognosis marker for cancer. We hypothesized that genetic variants of the HSPB1 gene may be associated with lung cancer susceptibility and survival. PATIENTS AND METHODS We first resequenced the full-length HSPB1 gene and then genotyped three selected tag single nucleotide polymorphisms (SNPs) in 1,152 paired Chinese lung cancer patient cases and controls. Another 500 paired patient cases and controls were used for replication. We also evaluated the roles of these tagSNPs in the overall survival of 248 patients with advanced non-small-cell lung cancer (NSCLC), and validated the results in another 335 patients with advanced NSCLC. The genotype-phenotype correlation was assessed in 309 workers with occupational exposure to polycyclic-aromatic hydrocarbons (PAHs) as well as by luciferase reporter assay and Western blotting analysis. RESULTS The -1271C allele was associated with a significantly increased lung cancer risk in the two independent patient case-control studies (P < .05 for both), but it conferred a favorable survival for patients with advanced NSCLC in two independent cohorts (adjusted hazard ratio, 0.66 and 0.75, respectively). The occupational PAH-exposed workers carrying the -1271C allele showed higher DNA damage levels than those with the -1271G allele (P = .027). Furthermore, the -1271C allele significantly decreased luciferase activity in four cell lines and resulted in lower Hsp27 expression levels in normal lung tissues when compared with -1271G allele (P < .05). CONCLUSION The functional HSPB1 promoter -1271G>C variant may affect lung cancer susceptibility and survival by modulating endogenous Hsp27 synthesis levels.

[1]  W. Tan,et al.  Functional FEN1 polymorphisms are associated with DNA damage levels and lung cancer risk , 2009, Human mutation.

[2]  Yongheng Chen,et al.  Identification of metastasis associated proteins in human lung squamous carcinoma using two-dimensional difference gel electrophoresis and laser capture microdissection. , 2009, Lung cancer.

[3]  Keitaro Matsuo,et al.  Relapse-related molecular signature in lung adenocarcinomas identifies patients with dismal prognosis. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  David C Christiani,et al.  Genome-wide analysis of survival in early-stage non-small-cell lung cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  Li Zhou,et al.  Functional SNPs in HSPA1A Gene Predict Risk of Coronary Heart Disease , 2009, PloS one.

[6]  S. Lippman,et al.  Lung cancer. , 2008, The New England journal of medicine.

[7]  Igor Jurisica,et al.  Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study , 2008, Nature Medicine.

[8]  Hongbing Shen,et al.  Genetic variants of miRNA sequences and non-small cell lung cancer survival. , 2008, The Journal of clinical investigation.

[9]  A. Jemal,et al.  Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.

[10]  Stuart K. Calderwood,et al.  Heat shock proteins: Stress proteins with Janus-like properties in cancer , 2008, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[11]  M. Sherman,et al.  Hsp27 modulates p53 signaling and suppresses cellular senescence. , 2007, Cancer research.

[12]  S. Maehara,et al.  Proteomics finding heat shock protein 27 as a biomarker for resistance of pancreatic cancer cells to gemcitabine. , 2007, International journal of oncology.

[13]  N. Chebotareva,et al.  Small heat shock protein Hsp27 prevents heat‐induced aggregation of F‐actin by forming soluble complexes with denatured actin , 2007, The FEBS journal.

[14]  C. van Broeckhoven,et al.  Genetic variant in the HSPB1 promoter region impairs the HSP27 stress response , 2007, Human mutation.

[15]  S. Simon,et al.  Hsp27 (HspB1) and αB‐crystallin (HspB5) as therapeutic targets , 2007 .

[16]  L. Vargas-Roig,et al.  Hsp27, Hsp70 and mismatch repair proteins hMLH1 and hMSH2 expression in peripheral blood lymphocytes from healthy subjects and cancer patients. , 2007, Cancer letters.

[17]  Hae-June Lee,et al.  Inhibition of heat shock protein 27-mediated resistance to DNA damaging agents by a novel PKC delta-V5 heptapeptide. , 2007, Cancer research.

[18]  Xun Shen,et al.  Heat Shock Protein 27 Protects L929 Cells from Cisplatin-Induced Apoptosis by Enhancing Akt Activation and Abating Suppression of Thioredoxin Reductase Activity , 2007, Clinical Cancer Research.

[19]  Hongbing Shen,et al.  Sequence variations in DNA repair gene XPC is associated with lung cancer risk in a Chinese population: a case-control study , 2007, BMC Cancer.

[20]  Q. Wei,et al.  Association between plasma BPDE-Alb adduct concentrations and DNA damage of peripheral blood lymphocytes among coke oven workers , 2007, Occupational and Environmental Medicine.

[21]  D. A. Tregouet,et al.  A new JAVA interface implementation of THESIAS: testing haplotype effects in association studies , 2007, Bioinform..

[22]  Zhong Zheng,et al.  DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer. , 2007, The New England journal of medicine.

[23]  M. Gleave,et al.  Hsp27 knockdown using nucleotide-based therapies inhibit tumor growth and enhance chemotherapy in human bladder cancer cells , 2007, Molecular Cancer Therapeutics.

[24]  P Boffetta,et al.  Occupational exposures to polycyclic aromatic hydrocarbons, and respiratory and urinary tract cancers: a quantitative review to 2005. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[25]  S. Simon,et al.  Hsp27 (HspB1) and alphaB-crystallin (HspB5) as therapeutic targets. , 2007, FEBS letters.

[26]  D. Sawyer,et al.  Heat shock proteins in cancer: chaperones of tumorigenesis. , 2006, Trends in biochemical sciences.

[27]  Su-Jae Lee,et al.  HSP25 inhibits radiation-induced apoptosis through reduction of PKCδ-mediated ROS production , 2005, Oncogene.

[28]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[29]  Stuart K. Calderwood,et al.  Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications , 2005, Cell stress & chaperones.

[30]  F. Bray,et al.  Estimation and projection of the national profile of cancer mortality in China: 1991–2005 , 2004, British Journal of Cancer.

[31]  R. Morimoto,et al.  Molecular chaperones and the stress of oncogenesis , 2004, Oncogene.

[32]  C. Concannon,et al.  On the role of Hsp27 in regulating apoptosis , 2004, Apoptosis.

[33]  N. Munshi,et al.  Hsp27 inhibits release of mitochondrial protein Smac in multiple myeloma cells and confers dexamethasone resistance. , 2003, Blood.

[34]  Peter Donnelly,et al.  A comparison of bayesian methods for haplotype reconstruction from population genotype data. , 2003, American journal of human genetics.

[35]  D. Ciocca,et al.  Hsp25 and Hsp70 in rodent tumors treated with doxorubicin and lovastatin , 2003, Cell stress & chaperones.

[36]  J. Bousquet,et al.  Heat shock protein-27 protects human bronchial epithelial cells against oxidative stress–mediated apoptosis: possible implication in asthma , 2002, Cell stress & chaperones.

[37]  V. Sukhatme,et al.  Endostatin Causes G1 Arrest of Endothelial Cells through Inhibition of Cyclin D1* , 2002, The Journal of Biological Chemistry.

[38]  S. Gonin,et al.  Hsp 27 as a Negative Regulator of Cytochrome c Release , 2001 .

[39]  Jacques Landry,et al.  Inhibition of Daxx-Mediated Apoptosis by Heat Shock Protein 27 , 2000, Molecular and Cellular Biology.

[40]  Guido Kroemer,et al.  Hsp27 negatively regulates cell death by interacting with cytochrome c , 2000, Nature Cell Biology.

[41]  C. Harris,et al.  Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[42]  W. Franklin,et al.  Heat-Shock Proteins Associated with Base Excision Repair Enzymes in HeLa Cells , 2000, Radiation research.

[43]  E. Solary,et al.  Heat shock protein 27 enhances the tumorigenicity of immunogenic rat colon carcinoma cell clones. , 1998, Cancer research.

[44]  Richard A. Szucs,et al.  TNM Classification of Malignant Tumors. 5th ed , 1998 .

[45]  W. McGuire,et al.  Biological and clinical implications of heat shock protein 27,000 (Hsp27): a review. , 1993, Journal of the National Cancer Institute.

[46]  W. McGuire,et al.  Biological and clinical implications of heat shock protein 27,000 (Hsp27): a review. , 1993, Journal of the National Cancer Institute.

[47]  H. Hansen,et al.  Lung cancer. , 1990, Cancer chemotherapy and biological response modifiers.

[48]  R. Tice,et al.  A simple technique for quantitation of low levels of DNA damage in individual cells. , 1988, Experimental cell research.

[49]  L. Sobin,et al.  TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.